Intelligence / AOD-9604

AOD-9604

Prescription Only
Fat Metabolism
Schedule
S4
Prescription Only
Enforcement
Stable
Low Risk
Providers
8
Access: Clear
Key Facts
Schedule 4 - Prescription Only
Fragment of human growth hormone (aa 177-191)
Studied for fat metabolism
Largely made obsolete by GLP-1 agents
Previously FDA Category 2

Overview

AOD-9604 is a fragment of human growth hormone (amino acids 177-191) studied for fat metabolism. Previously placed on FDA Category 2, it is expected to return to Category 1 under Kennedy reclassification. Largely made obsolete by GLP-1 agents for weight loss but still prescribed by some Australian clinics.

Australian Scheduling

Schedule 4 (Prescription Only). Enforcement is stable. Previously FDA Category 2, expected to return to Category 1 under Kennedy reclassification.

Access Pathway

Available through prescription from 8 identified Australian providers. Compounding pharmacies can supply under standard S4 pathways.

Regulatory Notice

For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.

Are You a Practitioner?

List your clinic for free and reach patients actively searching for legal peptide access in Australia.